Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

TB4 to be studied in phase II trial for venous stasis ulcers

Jan. 20, 2005

Endpoint not met in phase IIb study of Fibrostat for hypertrophic scars

Jan. 20, 2005

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Jan. 18, 2005

Xoma restructures Raptiva agreement with Genentech

Jan. 17, 2005

Phase II planned for PTH (1-34) after merger

Jan. 17, 2005

Positive data for oral Rambazole in psoriasis

Jan. 14, 2005

CB-03-01: a novel, selective androgen antagonist for topical use

Jan. 13, 2005

Positive preclinical findings for Zeatin and cytokinin compounds

Jan. 11, 2005

Phase II AVAC study in childhood eczema fails to meet primary endpoint

Dec. 29, 2004

Bz-423, a novel benzodiazepine, suppresses cell growth in an in vitro psoriasis model

Dec. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...